Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

19.7%

223 terminated/withdrawn out of 1134 trials

Success Rate

72.4%

-14.1% vs industry average

Late-Stage Pipeline

12%

138 trials in Phase 3/4

Results Transparency

52%

302 of 584 completed trials have results

Key Signals

164 recruiting302 with results154 terminated69 withdrawn

Enrollment Performance

Analytics

N/A

432(50.2%)

Phase 2

163(19.0%)

Phase 1

110(12.8%)

Phase 4

100(11.6%)

Phase 3

38(4.4%)

Early Phase 1

17(2.0%)

860Total

N/A(432)

Phase 2(163)

Phase 1(110)

Phase 4(100)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1134)

Showing 20 of 1134 trials

NCT03803332Not ApplicableRecruiting

A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel

Role: lead

NCT06560970Not ApplicableActive Not Recruiting

A Technology-based Psychosocial Intervention to Support Social Engagement and Well-being in Older Adults With HIV

Role: lead

NCT05272735Phase 4Terminated

HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers

Role: collaborator

NCT07386548Not ApplicableNot Yet Recruiting

Biologic Injection For Adults With Lumbar Disc Herniation

Role: lead

NCT06565104Not ApplicableRecruiting

The Sleep2BWell Trial

Role: collaborator

NCT06059664Phase 2Recruiting

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Role: collaborator

NCT07518953Not ApplicableNot Yet Recruiting

Effect of Music on Pain and Anxiety During Nail Biopsies

Role: lead

NCT02772588Phase 2Completed

AASUR in High Risk Prostate Cancer

Role: collaborator

NCT03601806Phase 2Completed

Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

Role: collaborator

NCT00859781Phase 2Active Not Recruiting

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Role: lead

NCT06456073Phase 1Recruiting

E-CEL UVEC Treatment for Anal Fissures

Role: lead

NCT01054196Phase 1Active Not Recruiting

Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study

Role: lead

NCT06746129Phase 3Recruiting

Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos

Role: collaborator

NCT05618366Phase 1Terminated

Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma

Role: lead

NCT05994235Phase 2Active Not Recruiting

Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma

Role: lead

NCT06818734Not ApplicableNot Yet Recruiting

Implementation of a Clinical Decision Support Tool for Postpartum Depression

Role: lead

NCT06225986Not ApplicableCompleted

Living Memory Home-4-Dementia Care Pairs

Role: lead

NCT04124120Not ApplicableRecruiting

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Role: lead

NCT05999240Phase 2Recruiting

Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder

Role: collaborator

NCT06300463Phase 2Recruiting

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

Role: lead